A new way for pharmaceutical companies and prescribers to interact?

By David Woods ([email protected]) Call them Sermoans, Sermophiles, or just plain members, the 32,000 physicians enrolled in Sermo could be changing the way that pharmaceutical companies interact with healthcare professionals. Certainly Pfizer thinks so. Having laid off 20% of its US and European sales teams last year, it recently linked up with Sermo – an…

You need to know the global issues in health economics

By Robert Hand ([email protected]) As a health economist and outcomes researcher, you may work primarily within a single country. Naturally, you know the economic, regulatory, and management issues of that country. However, with globalisation, you need increasingly to be aware of the corresponding conditions around the world. Why? Individual countries or cooperative groups of countries…